The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.
A research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known ...
During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.
Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but ...
Investing.com -- Vertex Pharmaceuticals Inc (NASDAQ: VRTX ).’s newly approved non-opioid pain medication, Journavx, has been included in UnitedHealth Group Inc (NYSE: UNH ).’s coverage, according to ...
Despite widespread public health warnings and media attention focused on the dangers of opioid addiction ... of nerve-injury ...
Vertex Pharmaceuticals Inc.’s new non-opioid painkiller ... might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists. The medication, called Journavx ...